Healthcare News
Tirzepatide associated with greater weight loss in women than men
All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss.
Weight-loss success depends on eating more protein and fiber while limiting calories, study says
Participants on a self-directed dietary education program who had the greatest success at losing weight across a 25-month period consumed greater amounts of protein and fiber, a study found.
Semaglutide and tirzepatide lead to better blood sugar control and weight loss in type 1 diabetes, study finds
Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) held in Madrid, Spain (9–13 September) has found.
Good sleep habits important for overweight adults, study suggests
New research from Oregon Health & Science University reveals negative health consequences for people who are overweight and ignore their body's signals to sleep at night.
Weight-loss jabs linked to lower cancer risk compared with insulin new study
Researchers in the US wanted to know if weight-loss drugs known as GLP-1 agonists reduced the risk of people getting any of the 13 cancers associated with obesity. Their results were recently published in JAMA Network Open.
